Pages that link to "Q28266158"
Jump to navigation
Jump to search
The following pages link to Association between common variants near the melanocortin 4 receptor gene and severe antipsychotic drug-induced weight gain (Q28266158):
Displaying 50 items.
- Biomarkers for drug development in early psychosis: Current issues and promising directions (Q26752612) (← links)
- Decoding the non-coding genome: elucidating genetic risk outside the coding genome (Q26777924) (← links)
- Pharmacogenetics and outcome with antipsychotic drugs (Q26852807) (← links)
- Genetics of Common Antipsychotic-Induced Adverse Effects (Q28072893) (← links)
- Treatment-resistant schizophrenia: current insights on the pharmacogenomics of antipsychotics (Q28079065) (← links)
- Progress in understanding the genomic basis for adverse drug reactions: a comprehensive review and focus on the role of ethnicity (Q28083100) (← links)
- MC4R rs489693: a clinical risk factor for second generation antipsychotic-related weight gain? (Q28296094) (← links)
- Schizophrenia. (Q30251961) (← links)
- Molecular substrates of schizophrenia: homeostatic signaling to connectivity (Q30383611) (← links)
- Towards the clinical implementation of pharmacogenetics in bipolar disorder. (Q33688133) (← links)
- Comparative efficacy and safety of antipsychotics in the treatment of schizophrenia: a network meta-analysis in a Japanese population (Q33713759) (← links)
- Pharmacogenetics of antipsychotics (Q33836837) (← links)
- Identification of candidate single-nucleotide polymorphisms in NRXN1 related to antipsychotic treatment response in patients with schizophrenia (Q33923615) (← links)
- The role of leptin, melanocortin, and neurotrophin system genes on body weight in anorexia nervosa and bulimia nervosa (Q34315012) (← links)
- Managing cardiovascular disease risk in patients treated with antipsychotics: a multidisciplinary approach (Q34464293) (← links)
- Association between MC4R rs17782313 polymorphism and overeating behaviors (Q34514174) (← links)
- Positive perception of pharmacogenetic testing for psychotropic medications (Q34541288) (← links)
- Aripiprazole for the management of schizophrenia in the Japanese population: a systematic review and meta-analysis of randomized controlled trials (Q35136085) (← links)
- Genome-wide association studies in Africans and African Americans: expanding the framework of the genomics of human traits and disease (Q35565624) (← links)
- Pharmacogenetics of clozapine treatment response and side-effects in schizophrenia: an update (Q35771833) (← links)
- Influence of MCHR2 and MCHR2-AS1 Genetic Polymorphisms on Body Mass Index in Psychiatric Patients and In Population-Based Subjects with Present or Past Atypical Depression (Q35804713) (← links)
- Taking Personalized Medicine Seriously: Biomarker Approaches in Phase IIb/III Studies in Major Depression and Schizophrenia (Q36063627) (← links)
- Recent advances in understanding and mitigating adipogenic and metabolic effects of antipsychotic drugs (Q36063735) (← links)
- An Economic Evaluation of a Weight Loss Intervention Program for People with Serious Mental Illnesses Taking Antipsychotic Medications (Q36441253) (← links)
- Pharmacogenetics of antipsychotics: recent progress and methodological issues (Q36539833) (← links)
- Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study (Q36746449) (← links)
- Genome-Wide Association Study Suggested the PTPRD Polymorphisms Were Associated With Weight Gain Effects of Atypical Antipsychotic Medications. (Q36817242) (← links)
- Is Metabolic Syndrome On the Radar? Improving Real-Time Detection of Metabolic Syndrome and Physician Response by Computerized Scan of the Electronic Medical Record (Q36921831) (← links)
- Moderation of antipsychotic-induced weight gain by energy balance gene variants in the RUPP autism network risperidone studies. (Q36956632) (← links)
- Genes and schizophrenia: from a Festschrift Seminar honoring William T. Carpenter Jr, MD. (Q37602618) (← links)
- Cardiometabolic outcomes in children and adolescents following discontinuation of long-term risperidone treatment (Q37712697) (← links)
- TOX and ADIPOQ Gene Polymorphisms Are Associated with Antipsychotic-Induced Weight Gain in Han Chinese (Q37714911) (← links)
- Weight gain and increase of body mass index among children and adolescents treated with antipsychotics: a critical review (Q38090490) (← links)
- Bringing genome-wide association findings into clinical use. (Q38120138) (← links)
- Novel "thrifty" models of increased eating behaviour. (Q38140664) (← links)
- Pharmacogenetics in schizophrenia: a review of clozapine studies (Q38154175) (← links)
- Clinical validity of cytochrome P450 metabolism and serotonin gene variants in psychiatric pharmacotherapy (Q38154911) (← links)
- Safety profile of iloperidone in the treatment of schizophrenia (Q38160942) (← links)
- Genetics of antipsychotic-induced weight gain: update and current perspectives (Q38166456) (← links)
- Individualizing clozapine and risperidone treatment for schizophrenia patients (Q38170458) (← links)
- Directions for future patient-centered and comparative effectiveness research for people with serious mental illness in a learning mental health care system (Q38184528) (← links)
- Pharmacogenetics of second-generation antipsychotics (Q38217628) (← links)
- Antipsychotic induced weight gain: genetics, epigenetics, and biomarkers reviewed. (Q38241344) (← links)
- Melanocortin Receptor-4 Gene Polymorphisms in Glioblastoma Patients Treated with Concomitant Radio-Chemotherapy (Q38381406) (← links)
- Weight gain and obesity in schizophrenia: epidemiology, pathobiology, and management (Q38504254) (← links)
- Metabolic side effects and pharmacogenetics of second-generation antipsychotics in children (Q38536898) (← links)
- Intrinsic and Antipsychotic Drug-Induced Metabolic Dysfunction in Schizophrenia (Q38626655) (← links)
- Pharmacogenetic Associations of Antipsychotic Drug-Related Weight Gain: A Systematic Review and Meta-analysis (Q38842714) (← links)
- Clozapine as a Model for Antipsychotic Development (Q39400094) (← links)
- Fine-mapping of antipsychotic response genome-wide association studies reveals novel regulatory mechanisms (Q40418374) (← links)